Xencor reported $0 in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amgen AMGN:US $ 32782M 97M
Arrowhead Research ARWR:US $ 0M 0M
AstraZeneca AZN:LN 27495M 7363M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Cytokinetics CYTK:US $ 139.14M 1.75M
Epizyme EPZM:US $ 231.2M 0.69M
GlaxoSmithKline GSK:LN 25483M 736M
Johnson & Johnson JNJ:US $ 33483M 130M
Karyopharm Therapeutics KPTI:US $ 301.38M 59.58M
Macrogenics MGNX:US $ 0M 0M
Novartis NOVN:VX SF 35769M 2030M
Regeneron Pharmaceuticals REGN:US $ 2697.6M 0.9M
Seattle Genetics SGEN:US $ 0M 0M
Xencor XNCR:US $ 0M 0M